West Pharmaceutical Services (WST) Proxy Filing summary

Executive summary

• Annual meeting scheduled for May 4, 2026, with virtual attendance available for shareholders.

• Shareholders are encouraged to review proxy materials and annual report before voting.

Voting matters and shareholder proposals

• Election of eleven directors is on the agenda, with all nominees recommended by the board.

• Advisory vote on named executive officer compensation (say-on-pay) is included.

• Ratification of the independent registered public accounting firm for 2026 is proposed.

• Shareholder proposal regarding adoption of an independent Board Chair policy is up for vote, with the board recommending against it.

Board of directors and corporate governance

• Eleven director nominees are presented for election at the annual meeting.

• Board recommends all nominees for election.